NOVIRIO PHARMACEUTICALS LTD has a total of 29 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, Argentina and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are IDENIX PHARMACEUTICALS INC, IDENIX CAYMAN LTD and WITTYCELL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Argentina | 4 | |
#3 | Taiwan | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | United States | 2 | |
#9 | Brazil | 1 | |
#10 | Mexico | 1 | |
#11 | Malaysia | 1 | |
#12 | African Intellectual Property Organization | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Optics | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Sommadossi Jean-Pierre | 11 |
#2 | Bryant Martin L | 10 |
#3 | Artico Marino | 5 |
#4 | Gosselin Gilles | 4 |
#5 | Imbach Jean-Louis | 4 |
#6 | La Colla Paolo | 4 |
#7 | Colla Paolo La | 3 |
#8 | Lacolla Paolo | 3 |
#9 | Jean-Pierre Sommadossi | 2 |
#10 | Lacolla Paulo | 2 |
Publication | Filing date | Title |
---|---|---|
MY141594A | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES | |
WO0192282A2 | Methods and compositions for treating flaviviruses and pestiviruses | |
US6444652B1 | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B | |
BR9912142A | Substituted 6-benzyl-4-oxypyrimidines, process for their preparation and compositions containing them |